Cormorant Asset Management LP 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 3:07 pm Sale | 2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Cormorant Asset Management LP | 2,550,000 4.390% | -300,000 (-10.53%) | Filing |
2023-10-23 4:02 pm Purchase | 2023-10-11 | 13G | Alpine Immune Sciences, Inc. ALPN | Cormorant Asset Management LP | 2,850,000 5.790% | 2,850,000 (New Position) | Filing |